Effects of exercise training combined with insulin treatment on cardiac NOS1 signaling pathways in type 1 diabetic rats

Mol Cell Biochem. 2011 Jan;347(1-2):53-62. doi: 10.1007/s11010-010-0611-6. Epub 2010 Oct 9.

Abstract

This study examined the effects of a dual treatment combining insulin treatment and exercise training on basal cardiac function and signaling pathways involving β3-AR, NOS1, and RyR2 in type 1 diabetic rats. Male Wistar rats were assigned into a diabetic group receiving no treatment (D), an insulin-treated diabetic (Ins), a trained diabetic (TD), and a trained insulin-treated diabetic (TIns) group. Control group (C) was included in order to confirm the deleterious effects of diabetes. Insulin treatment and/or treadmill exercise training were conducted for 8 weeks. Basal cardiac function was evaluated by Langendorff technique. Cardiac protein expression of β3-AR, NOS1, and RyR2 was assessed using Western blots. Diabetes induced a decrease of both basal diastolic and systolic (±dP/dt) cardiac function (P < 0.05). Moreover, diabetes was associated with an increase of β3-AR and NOS1 and a decrease of RyR2 expression (P < 0.05). Although combined treatment was not able to normalize -dP/dt, it succeeded to normalize +dP/dt of diabetic rats. Combined treatment led to an overexpression of RyR2. Effects of this combined treatment on +dP/dt and RyR2 were greater than the effects of insulin and exercise training, applied solely. Treatments, applied solely or in combination, resulted in a complete normalization of β3-AR and in a down-regulation of NOS1 because this protein expression in all treated diabetic rats became lower than control values (P < 0.01). Our study shows that unlike single treatments, dual treatment combining insulin treatment and exercise training was able to normalize basal systolic function of diabetic rats by a specific regulation of β3-AR-NOS1-RyR2 signaling pathways.

MeSH terms

  • Animals
  • Blood Glucose / drug effects
  • Blood Pressure / drug effects
  • Body Weight / drug effects
  • Citrate (si)-Synthase / metabolism
  • Diabetes Mellitus, Experimental / enzymology*
  • Diabetes Mellitus, Experimental / physiopathology
  • Diabetes Mellitus, Type 1 / enzymology*
  • Diabetes Mellitus, Type 1 / physiopathology
  • Diastole / drug effects
  • Heart Rate / drug effects
  • Heart Ventricles / enzymology
  • Heart Ventricles / pathology
  • Heart Ventricles / physiopathology
  • In Vitro Techniques
  • Insulin / administration & dosage*
  • Insulin / pharmacology*
  • Male
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / enzymology
  • Myocardium / enzymology*
  • Nitric Oxide Synthase / metabolism*
  • Nitric Oxide Synthase Type I
  • Organ Size / drug effects
  • Physical Conditioning, Animal*
  • Rats
  • Rats, Wistar
  • Receptors, Adrenergic, beta-3 / metabolism
  • Ryanodine Receptor Calcium Release Channel / metabolism
  • Signal Transduction / drug effects
  • Systole / drug effects

Substances

  • Blood Glucose
  • Insulin
  • Receptors, Adrenergic, beta-3
  • Ryanodine Receptor Calcium Release Channel
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type I
  • Nos1 protein, rat
  • Citrate (si)-Synthase